Authors:
BREUER B
SMITH S
THOR A
EDGERTON S
OSBORNE MP
MINICK R
CODY HS
NOWAK E
CORTESE A
SIMMONS RM
CARNEY WP
BRANDTRAUF PW
Citation: B. Breuer et al., ERBB-2 PROTEIN IN SERA AND TUMORS OF BREAST-CANCER PATIENTS, Breast cancer research and treatment, 49(3), 1998, pp. 261-270
Authors:
SMITH SJ
LI YL
WHITLEY R
MARION MJ
PARTILO S
CARNEY WP
BRANDTRAUF PW
Citation: Sj. Smith et al., MOLECULAR EPIDEMIOLOGY OF P53 PROTEIN MUTATIONS IN WORKERS EXPOSED TOVINYL-CHLORIDE, American journal of epidemiology, 147(3), 1998, pp. 302-308
Authors:
HUSGAFVELPURSIAINEN K
KANNIO A
OKSA P
SUITIALA T
KOSKINEN H
PARTANEN R
HEMMINKI K
SMITH S
ROSENSTOCKLEIBU R
BRANDTRAUF PW
Citation: K. Husgafvelpursiainen et al., MUTATIONS, TISSUE ACCUMULATIONS, AND SERUM LEVELS OF P53 IN PATIENTS WITH OCCUPATIONAL CANCERS FROM ASBESTOS AND SILICA EXPOSURE, Environmental and molecular mutagenesis, 30(2), 1997, pp. 224-230
Authors:
CHEN JM
MONACO R
MANOLATOS S
BRANDTRAUF PW
FRIEDMAN FK
PINCUS MR
Citation: Jm. Chen et al., MOLECULAR-DYNAMICS ON COMPLEXES OF RAS-P21 AND ITS INHIBITOR PROTEIN,RAP-1A, BOUND TO THE RAS BINDING DOMAIN OF THE RAF-P74 PROTEIN - IDENTIFICATION OF EFFECTOR DOMAINS IN THE RAF PROTEIN, Journal of protein chemistry, 16(6), 1997, pp. 619-629
Authors:
ADLER V
PINCUS MR
MINAMOTO T
FUCHS SY
BLUTH MJ
BRANDTRAUF PW
FRIEDMAN FK
ROBINSON RC
CHEN JM
WANG XW
HARRIS CC
RONAI Z
Citation: V. Adler et al., CONFORMATION-DEPENDENT PHOSPHORYLATION OF P53, Proceedings of the National Academy of Sciences of the United Statesof America, 94(5), 1997, pp. 1686-1691
Authors:
LUO JC
NEUGUT AI
GARBOWSKI G
FORDE KA
TREAT M
SMITH S
NIMAN H
BRANDTRAUF PW
Citation: Jc. Luo et al., EXPRESSION OF P21RAS-RELATED PROTEIN IN THE PLASMA AND TISSUE OF PATIENTS WITH ADENOMAS AND CARCINOMAS OF THE COLON, Biomarkers, 1(1), 1996, pp. 29-33
Citation: Jm. Chen et al., ONCOGENIC AMINO-ACID SUBSTITUTIONS IN THE INHIBITORY RAP-1A PROTEIN CAUSE IT TO ADOPT A RAS-P21-LIKE CONFORMATION AS COMPUTED USING MOLECULAR-DYNAMICS, Journal of biomolecular structure & dynamics, 13(6), 1996, pp. 925-933
Authors:
MARION MJ
DEVIVO I
SMITH S
LUO JC
BRANDTRAUF PW
Citation: Mj. Marion et al., THE MOLECULAR EPIDEMIOLOGY OF OCCUPATIONAL CARCINOGENESIS IN VINYL-CHLORIDE EXPOSED WORKERS, International archives of occupational and environmental health, 68(6), 1996, pp. 394-398
Authors:
CHEN JM
MANOLATOS S
BRANDTRAUF PW
MURPHY RB
MONACO R
PINCUS MR
Citation: Jm. Chen et al., COMPUTED 3-DIMENSIONAL STRUCTURES FOR THE RAS-BINDING DOMAIN OF THE RAF-P74 PROTEIN COMPLEXED WITH RAS-P21 AND WITH ITS SUPPRESSOR PROTEIN,RAP-1A, Journal of protein chemistry, 15(6), 1996, pp. 511-518
Authors:
BRANDTRAUF PW
CHEN JM
MARION MJ
SMITH SJ
LUO JC
CARNEY W
PINCUS MR
Citation: Pw. Brandtrauf et al., CONFORMATIONAL EFFECTS IN THE P53 PROTEIN OF MUTATIONS INDUCED DURINGCHEMICAL CARCINOGENESIS - MOLECULAR DYNAMIC AND IMMUNOLOGICAL ANALYSES, Journal of protein chemistry, 15(4), 1996, pp. 367-375
Authors:
HEMMINKI K
PARTANEN R
KOSKINEN H
SMITH S
CARNEY W
BRANDTRAUF PW
Citation: K. Hemminki et al., THE MOLECULAR EPIDEMIOLOGY OF ONCOPROTEINS - SERUM P53 PROTEIN IN PATIENTS WITH ASBESTOSIS, Chest, 109(3), 1996, pp. 22-26
Authors:
BRANDTRAUF PW
DEVIVO I
MARION MJ
HEMMINKI K
Citation: Pw. Brandtrauf et al., THE MOLECULAR EPIDEMIOLOGY OF GROWTH SIGNAL-TRANSDUCTION PROTEINS, Journal of occupational and environmental medicine, 37(1), 1995, pp. 77-83
Authors:
LUO JC
NEUGUT AI
GARBOWSKI G
FORDE KA
TREAT M
SMITH S
CARNEY WP
BRANDTRAUF PW
Citation: Jc. Luo et al., LEVELS OF P53 ANTIGEN IN THE PLASMA OF PATIENTS WITH ADENOMAS AND CARCINOMAS OF THE COLON, Cancer letters, 91(2), 1995, pp. 235-240
Citation: Pw. Brandtrauf et al., CONFORMATION OF THE TRANSMEMBRANE DOMAIN OF THE C-ERBB-2 ONCOGENE-ENCODED PROTEIN IN ITS MONOMERIC AND DIMERIC STATES, Journal of protein chemistry, 14(1), 1995, pp. 33-40
Authors:
HASPEL J
DENT P
HAYSTEAD T
BRANDTRAUF PW
CHUNG D
WEINSTEIN IB
NISHIMURA S
YAMAIZUMI Z
PINCUS MR
Citation: J. Haspel et al., RAF-INDUCED KINASES MAY BE NECESSARY BUT ARE NOT SUFFICIENT FOR RAS-P21-PROTEIN INDUCTION OF OOCYTE MATURATION, Medical science research, 23(7), 1995, pp. 455-457
Citation: V. Adler et al., COMPLEXES OF P21(RAS) WITH JUN N-TERMINAL KINASE AND JUN PROTEINS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(23), 1995, pp. 10585-10589
Citation: Pw. Brandtrauf, THE C-ERBB TRANSMEMBRANE GROWTH-FACTOR RECEPTORS AS SERUM BIOMARKERS IN HUMAN CANCER STUDIES, Mutation research, 333(1-2), 1995, pp. 203-208
Authors:
BREUER B
DEVIVO I
LUO JC
SMITH S
PINCUS MR
TATUM AH
DAUCHER J
MINICK CR
MILLER DG
NOWAK EJ
CODY HS
NIMAN H
CARNEY WP
BRANDTRAUF PW
Citation: B. Breuer et al., ERBB-2 AND MYC ONCOPROTEINS IN SERA AND TUMORS OF BREAST-CANCER PATIENTS, Cancer epidemiology, biomarkers & prevention, 3(1), 1994, pp. 63-66
Authors:
DEVIVO I
MARION MJ
SMITH SJ
CARNEY WP
BRANDTRAUF PW
Citation: I. Devivo et al., MUTANT C-KI-RAS P21 PROTEIN IN CHEMICAL CARCINOGENESIS IN HUMANS EXPOSED TO VINYL-CHLORIDE, CCC. Cancer causes & control, 5(3), 1994, pp. 273-278
Citation: Pw. Brandtrauf et al., THE C-ERB-2 PROTEIN IN ONCOGENESIS - MOLECULAR-STRUCTURE TO MOLECULAREPIDEMIOLOGY, Critical reviews in oncogenesis, 5(2-3), 1994, pp. 313-329
Citation: Pw. Brandtrauf et al., CONFORMATION OF THE TRANSMEMBRANE DOMAIN OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR, Journal of protein chemistry, 13(2), 1994, pp. 227-231